ACTUATE THERAPEUTICS REPORTS POSITIVE MONOTHERAPY DATA IN AGGRESSIVE MELANOMA PRECLINICAL MODEL WITH DAILY DOSING OF ELRAGLUSIB ORAL TABLET AT ENA 2026

Reuters · 3d ago

Please log in to view news